Monographie - Moxifloxacin - Stabilis 4.0

Zadnji put ažurirano :
19/11/2024

antibiotik

Moxifloxacin

injekcija

oralna otopina

Stabilizacija rješenja

Stabilnost mješavine

Stabilizacijski faktor

Kompatibilnosti

način davanja lijeka

Bibliografija

pdf

Kemijska struktura

Nekomercijalni

Nekomercijalni

Zaštićeni nazivi su indikativni i sastav ekscipijensa može biti različit ovisno o državi i laboratorijima

Actira	Luksemburg, Nizozemska, Španjolska, Švedska
Avalox	Argentina, Australija, Belgija, Brazil, Čile, Danska, Ekvador, Finska, Irska, Kanada, Kolumbija, Madžarska, Malezija, Maroko, Meksiko, Nizozemska, Njemačka, novi Zeland, Peru, Rumunjska, S A D, Saudijska Arabija, Švedska, Turska, Ujedinjeni Arapski Emirati, Venecuela
Axokine	Venecuela
Mahaflox	Indija
Mofelox	Turska
Mofinacin	Rumunjska
Moflaxa	Rumunjska
Moksefen	Turska
Moksilox	Turska
Moxacin	Turska
Moxifix	Turska
Moxifloxin	Belgija, Njemačka
Moxifloxina	Rumunjska
Moxifloxino	Čile, Španjolska
Muzdil	Španjolska
Octegra	Nizozemska, Švedska
Pixiriv	Meksiko
Praiva	Ekvador, Peru
Proflox	Luksemburg

Bibliografija

injekcija

Bibliografija : Moxifloxacin

	Vrsta	Publikacija
2017	Časopis	Barker B, Feddema S, Rusho WJ, Dengg R. Visual compatibility of vasopressin with other injectable drugs. Am J Health-Syst Pharm 2005 ; 62: 1969-1976.
2145	Časopis	Fernandez-Varon E, Marin P, Espuny A, Villamayor L, Escudero E, Carceles C. Stability of moxifloxacin injection in peritoneal dialysis solution bags (Dianeal PD1 1.36%® and Dianeal PD1 3.86%®). J Clin Pharm Ther 2006 ; 31: 641-643.
2231	Časopis	de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 2008 ; 61, 2: 382-388.
2262	Časopis	Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D. Compatibility of doripenem with other drugs during simulated Y-site administratioN Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
2269	Časopis	Chan P, Bishop A, Kupiec TC, Trissel LA, Gole D, Jimidar IM, Vermeersch H. Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2008 ; 65, 16: 1545-1551.
3109	Laboratorija	Moxifloxacine (Izilox®) -Notice information Bayer Schering Pharma 2010
3162	Laboratorija	Moxifloxacine (Izilox®) - Résumé des caractéristiques du produits Bayer HealthCare 2010
3249	Časopis	Singh BM, Dedhiya MG, Dinunzio J, Chan P, Kupiec TC, Trissel LA, Laudano JB. Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2011 ; 68: 2163-2169.
3385	Časopis	Raverdi V, Ampe E, Hecq JD, Tulkens PM. Stability and compatibility of vancomycin for administration by continuous infusion. J Antimicrob Chemother 2013 ; 68: 1179-1182.
3865	Časopis	Vicky M, Samit S, Jaymin P, Michael C T. Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration. Int J Pharm Compound 2016 ; 20, 3 : 236-238.
4650	Laboratorija	Ceftobiprole (Zevtera 500 mg powder for concentrate for solution for infusion.) Summary of Product Characteristics, Advanz Pharma updated 4 aug 2021. Advanz Pharma 2021
4758	Časopis	Schmidt J.P, Steppe M. Stability Study and Simultaneous Determination of Norepinephrine, Moxifloxacin, and Piperacillin + Tazobactam Mixtures Applied in Intensive Care Medicine . Curr Pharm Anal 2023 ; 19, 4: 307-316.

Mentions Légales